Literature DB >> 10866870

Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

J G Canto1, M G Shlipak, W J Rogers, J A Malmgren, P D Frederick, C T Lambrew, J P Ornato, H V Barron, C I Kiefe.   

Abstract

CONTEXT: Although chest pain is widely considered a key symptom in the diagnosis of myocardial infarction (MI), not all patients with MI present with chest pain. The extent to which this phenomenon occurs is largely unknown.
OBJECTIVES: To determine the frequency with which patients with MI present without chest pain and to examine their subsequent management and outcome.
DESIGN: Prospective observational study. SETTING AND PATIENTS: A total of 434,877 patients with confirmed MI enrolled June 1994 to March 1998 in the National Registry of Myocardial Infarction 2, which includes 1674 hospitals in the United States. MAIN OUTCOME MEASURES: Prevalence of presentation without chest pain; clinical characteristics, treatment, and mortality among MI patients without chest pain vs those with chest pain.
RESULTS: Of all patients diagnosed as having MI, 142,445 (33%) did not have chest pain on presentation to the hospital. This group of MI patients was, on average, 7 years older than those with chest pain (74.2 vs 66.9 years), with a higher proportion of women (49.0% vs 38.0%) and patients with diabetes mellitus (32.6% vs 25. 4%) or prior heart failure (26.4% vs 12.3%). Also, MI patients without chest pain had a longer delay before hospital presentation (mean, 7.9 vs 5.3 hours), were less likely to be diagnosed as having confirmed MI at the time of admission (22.2% vs 50.3%), and were less likely to receive thrombolysis or primary angioplasty (25.3% vs 74.0%), aspirin (60.4% vs 84.5%), beta-blockers (28.0% vs 48.0%), or heparin (53.4% vs 83.2%). Myocardial infarction patients without chest pain had a 23.3% in-hospital mortality rate compared with 9.3% among patients with chest pain (adjusted odds ratio for mortality, 2. 21 [95% confidence interval, 2.17-2.26]).
CONCLUSIONS: Our results suggest that patients without chest pain on presentation represent a large segment of the MI population and are at increased risk for delays in seeking medical attention, less aggressive treatments, and in-hospital mortality. JAMA. 2000;283:3223-3229

Entities:  

Mesh:

Year:  2000        PMID: 10866870     DOI: 10.1001/jama.283.24.3223

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  123 in total

1.  Cluster analysis of women's prodromal and acute myocardial infarction symptoms by race and other characteristics.

Authors:  Jean C McSweeney; Mario A Cleves; Weizhi Zhao; Leanne L Lefler; Shengping Yang
Journal:  J Cardiovasc Nurs       Date:  2010 Jul-Aug       Impact factor: 2.083

2.  Airborne collapse: an in-flight emergency.

Authors:  Michael Moore; Peter White; Pamela Royle
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

3.  A study of clinical presentation and delays in management of acute myocardial infarction in community.

Authors:  Pravin K Goel; Saurabh Kumar Srivastava; Fauzia Ashfaq; P R Gupta; P C Saxena; Rajeev Agarwal; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Aditya Kapoor
Journal:  Indian Heart J       Date:  2012 May-Jun

4.  Access to cardiac interventional services in Alabama and Mississippi: a geographical information system analysis.

Authors:  Barbara Ann Graves
Journal:  Perspect Health Inf Manag       Date:  2010-04-01

Review 5.  Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus.

Authors:  Yuji Kadoi
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

6.  Acute coronary syndrome: evaluation of detection capability using non-electrocardiogram-gated parenchymal phase CT imaging.

Authors:  Motohiko Yamazaki; Takeshi Higuchi; Toshikazu Shimokoshi; Takao Kiguchi; Yosuke Horii; Norihiko Yoshimura; Hidefumi Aoyama
Journal:  Jpn J Radiol       Date:  2016-02-16       Impact factor: 2.374

7.  Acute reperfusion therapy in ST-elevation myocardial infarction from 1994-2003.

Authors:  Brahmajee K Nallamothu; Martha E Blaney; Susan M Morris; Lori Parsons; Dave P Miller; John G Canto; Hal V Barron; Harlan M Krumholz
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

8.  Modifiable factors associated with prolonged door to balloon time in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Masahiko Noguchi; Junya Ako; Takeshi Morimoto; Yosuke Homma; Takashi Shiga; Kotaro Obunai; Hiroyuki Watanabe
Journal:  Heart Vessels       Date:  2018-05-07       Impact factor: 2.037

Review 9.  Diagnosis and treatment of diabetic autonomic neuropathy.

Authors:  D Ziegler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

10.  Quantitative segmental analysis of myocardial perfusion to differentiate stress cardiomyopathy from acute myocardial infarction: A myocardial contrast echocardiography study.

Authors:  Sun-Yang Min; Jong-Min Song; Yewon Shin; Min-Jung Sin; Dae-Hee Kim; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Clin Cardiol       Date:  2017-04-21       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.